Cargando…
pH-Responsive Nanocarriers in Cancer Therapy
A number of promising nano-sized particles (nanoparticles) have been developed to conquer the limitations of conventional chemotherapy. One of the most promising methods is stimuli-responsive nanoparticles because they enable the safe delivery of the drugs while controlling their release at the tumo...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912405/ https://www.ncbi.nlm.nih.gov/pubmed/35267759 http://dx.doi.org/10.3390/polym14050936 |
_version_ | 1784667119333408768 |
---|---|
author | AlSawaftah, Nour M. Awad, Nahid S. Pitt, William G. Husseini, Ghaleb A. |
author_facet | AlSawaftah, Nour M. Awad, Nahid S. Pitt, William G. Husseini, Ghaleb A. |
author_sort | AlSawaftah, Nour M. |
collection | PubMed |
description | A number of promising nano-sized particles (nanoparticles) have been developed to conquer the limitations of conventional chemotherapy. One of the most promising methods is stimuli-responsive nanoparticles because they enable the safe delivery of the drugs while controlling their release at the tumor sites. Different intrinsic and extrinsic stimuli can be used to trigger drug release such as temperature, redox, ultrasound, magnetic field, and pH. The intracellular pH of solid tumors is maintained below the extracellular pH. Thus, pH-sensitive nanoparticles are highly efficient in delivering drugs to tumors compared to conventional nanoparticles. This review provides a survey of the different strategies used to develop pH-sensitive nanoparticles used in cancer therapy. |
format | Online Article Text |
id | pubmed-8912405 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89124052022-03-11 pH-Responsive Nanocarriers in Cancer Therapy AlSawaftah, Nour M. Awad, Nahid S. Pitt, William G. Husseini, Ghaleb A. Polymers (Basel) Review A number of promising nano-sized particles (nanoparticles) have been developed to conquer the limitations of conventional chemotherapy. One of the most promising methods is stimuli-responsive nanoparticles because they enable the safe delivery of the drugs while controlling their release at the tumor sites. Different intrinsic and extrinsic stimuli can be used to trigger drug release such as temperature, redox, ultrasound, magnetic field, and pH. The intracellular pH of solid tumors is maintained below the extracellular pH. Thus, pH-sensitive nanoparticles are highly efficient in delivering drugs to tumors compared to conventional nanoparticles. This review provides a survey of the different strategies used to develop pH-sensitive nanoparticles used in cancer therapy. MDPI 2022-02-26 /pmc/articles/PMC8912405/ /pubmed/35267759 http://dx.doi.org/10.3390/polym14050936 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review AlSawaftah, Nour M. Awad, Nahid S. Pitt, William G. Husseini, Ghaleb A. pH-Responsive Nanocarriers in Cancer Therapy |
title | pH-Responsive Nanocarriers in Cancer Therapy |
title_full | pH-Responsive Nanocarriers in Cancer Therapy |
title_fullStr | pH-Responsive Nanocarriers in Cancer Therapy |
title_full_unstemmed | pH-Responsive Nanocarriers in Cancer Therapy |
title_short | pH-Responsive Nanocarriers in Cancer Therapy |
title_sort | ph-responsive nanocarriers in cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8912405/ https://www.ncbi.nlm.nih.gov/pubmed/35267759 http://dx.doi.org/10.3390/polym14050936 |
work_keys_str_mv | AT alsawaftahnourm phresponsivenanocarriersincancertherapy AT awadnahids phresponsivenanocarriersincancertherapy AT pittwilliamg phresponsivenanocarriersincancertherapy AT husseinighaleba phresponsivenanocarriersincancertherapy |